Stay connected to the latest clinical updates, teaching strategies, and practice-ready skills – delivered in a format that fits your busy life. Learn on your schedule without sacrificing quality or depth.
Stay current. Stay confident. Stay clinically sharp.
52 episodes. 30+ CE hours. $99 — less than $3 per hour.Weekly ACPE-accredited, relevant content you can watch, listen to, or download—anytime!
Racism is a public health emergency and a root cause of social determinants of health. If we are to practice… More Details
Recently news suggests low vitamin D levels have been associated with increased risk of COVID-related morbidity and mortality. We know… More Details
Recently, Remdesivir was given Emergency Use Authorization (EUA) status by the U.S. Food and Drug Administration (FDA) for use in… More Details
Buprenorphine has been shown in numerous studies to be safe and effective in opioid use disorder, yet < 10% patients… More Details
Geoff Wall, PharmD & Jamie Pitlick, PharmD discussing SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption… More Details
GameChangers: In this episode, we describe the latest information concerning hypercoagulability with COVID-19 infection. In this episode, we describe the… More Details
